Functional analysis LRP6 novel mutations in patients with coronary artery disease

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Xu, Yujun ^a,b   Gong, Wei ^a   Peng, Jia ^a,c   Wang, Haoran ^a   Huang, Jin ^a   Ding, Hu ^a,d   Wang, Dao Wen ^a,d  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; PROTEIN VARIANT;

ADULT; ARTICLE; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; EXON; FEMALE; GENE SEQUENCE; HUMAN; IN VITRO STUDY; LOSS OF FUNCTION MUTATION; MALE; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN TRANSPORT; UMBILICAL VEIN ENDOTHELIAL CELL; WNT SIGNALING PATHWAY; YOUNG ADULT;

ADULT; ALLELES; AMINO ACID SEQUENCE; CASE-CONTROL STUDIES; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CORONARY ARTERY DISEASE; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; MUTATION, MISSENSE; PROMOTER REGIONS, GENETIC; RISK FACTORS; SEQUENCE ALIGNMENT; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84897481258     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084345     Document Type: Article

References (29)

1. Weber C, Noels H (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17: 1410-1422.
2. Schunkert H, Erdmann J, Samani NJ (2010) Genetics of myocardial infarction: a progress report. Eur Heart J 31: 918-925.
3. Peden JF, Farrall M (2011) Thirty-five common variants for coronary artery disease: the fruits of much collaborative labour. Hum Mol Genet 20: R198-205.
4. Zhu X, Feng T, Li Y, Lu Q, Elston RC (2010) Detecting rare variants for complex traits using family and unrelated data. Genet Epidemiol 34: 171-187.
5. Bedel A, Negre-Salvayre A, Heeneman S, Grazide MH, Thiers JC, et al. (2008) E-cadherin/beta-catenin/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein. Circ Res 103: 694-701.
6. Tsaousi A, Williams H, Lyon CA, Taylor V, Swain A, et al. (2011) Wnt4/beta-catenin signaling induces VSMC proliferation and is associated with intimal thickening. Circ Res 108: 427-436.
7. Bilkovski R, Schulte DM, Oberhauser F, Mauer J, Hampel B, et al. (2011) Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via wnt-5a in humans. Int J Obes (Lond) 35: 1450-1454.
8. Smadja DM, d'Audigier C, Weiswald LB, Badoual C, Dangles-Marie V, et al. (2010) The Wnt antagonist Dickkopf-1 increases endothelial progenitor cell angiogenic potential. Arterioscler Thromb Vasc Biol 30: 2544-2552.
9. Lobov IB, Rao S, Carroll TJ, Vallance JE, Ito M, et al. (2005) WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 437: 417-421. (Pubitemid 41613504)
10. Sarzani R, Salvi F, Bordicchia M, Guerra F, Battistoni I, et al. (2011) Carotid artery atherosclerosis in hypertensive patients with a functional LDL receptor-related protein 6 gene variant. Nutr Metab Cardiovasc Dis 21: 150-156.
11. Mani A, Radhakrishnan J, Wang H, Mani MA, Nelson-Williams C, et al. (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315: 1278-1282. (Pubitemid 46364265)
12. Keramati AR, Singh R, Lin A, Faramarzi S, Ye ZJ, et al. (2011) Wild-type LRP6 inhibits, whereas atherosclerosis-linked LRP6R611C increases PDGF-dependent vascular smooth muscle cell proliferation. Proc Natl Acad Sci U S A 108: 1914-1918.
13. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948. (Pubitemid 350162903)
14. MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26.
15. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, et al. (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346: 1513-1521. (Pubitemid 34755690)
16. Hsu SC, Galceran J, Grosschedl R (1998) Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin. Mol Cell Biol 18: 4807-4818. (Pubitemid 28343065)
17. De Ferrari GV, Papassotiropoulos A, Biechele T, Wavrant De-Vrieze F, Avila ME, et al. (2007) Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease. Proc Natl Acad Sci U S A 104: 9434-9439. (Pubitemid 47185797)
18. Zheng L, Baumann U, Reymond JL (2004) An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic Acids Res 32: e115.
19. Ding H, Wu B, Wang H, Lu Z, Yan J, et al. (2010) A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease. Circ Res 106: 1145-1152.
20. Takimoto E, Koitabashi N, Hsu S, Ketner EA, Zhang M, et al. (2009) Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice. J Clin Invest 119: 408-420.
21. Wang Y, Wei X, Xiao X, Hui R, Card JW, et al. (2005) Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways. J Pharmacol Exp Ther 314: 522-532. (Pubitemid 41043832)
22. Tsaousi A, Mill C, George SJ (2011) The Wnt pathways in vascular disease: lessons from vascular development. Curr Opin Lipidol 22: 350-357.
23. Mi K, Johnson GV (2005) Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway. J Cell Biochem 95: 328-338. (Pubitemid 41420202)
24. Dejana E (2010) The role of wnt signaling in physiological and pathological angiogenesis. Circ Res 107: 943-952.
25. Gelfand BD, Meller J, Pryor AW, Kahn M, Bortz PD, et al. (2011) Hemodynamic activation of beta-catenin and T-cell-specific transcription factor signaling in vascular endothelium regulates fibronectin expression. Arterioscler Thromb Vasc Biol 31: 1625-1633.
26. Magoori K, Kang MJ, Ito MR, Kakuuchi H, Ioka RX, et al. (2003) Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E. J Biol Chem 278: 11331-11336. (Pubitemid 36792690)
27. He X, Semenov M, Tamai K, Zeng X (2004) LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 131: 1663-1677. (Pubitemid 38559836)
28. Bonetti PO, Lerman LO, Lerman A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23: 168-175. (Pubitemid 36231924)
29. Francis AA, Pierce GN (2011) An integrated approach for the mechanisms responsible for atherosclerotic plaque regression. Exp Clin Cardiol 16: 77-86.